Cannabis Market in North Dakota

Cannabis is legal for medical use only in North Dakota.

North Dakota voters approved Measure 5 in November 2016, establishing a medical cannabis program in the state. The first dispensaries opened in March 2019, and the program has grown steadily since. The program is administered by the North Dakota Department of Health and Human Services through its Division of Medical Marijuana, which oversees licensing, compliance, and patient registration.

The North Dakota market is limited in scope due to the state's small population of approximately 780,000 residents. Only 2 manufacturing facilities and 8 dispensary locations are licensed to operate statewide. Despite these constraints, the program serves a growing patient base and generates an estimated $40 million in annual sales. Qualifying conditions include cancer, PTSD, Crohn's disease, epilepsy, AIDS, ALS, and conditions causing chronic or debilitating pain.

Recreational legalization has been attempted but rejected by voters. Measure 2, a recreational cannabis initiative, appeared on the ballot in November 2018 but was defeated with approximately 59% of voters opposing the measure. A subsequent recreational measure also failed in 2022. Despite these defeats, the medical program continues to serve patients effectively. No major MSOs operate in North Dakota, as the small market size and limited license availability make the state less attractive for large operators. The market is served by local operators who hold the state's limited manufacturing and dispensary licenses.

The North Dakota cannabis market is regulated by the North Dakota Department of Health and Human Services — Division of Medical Marijuana, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in North Dakota is: 5% state sales tax on medical cannabis plus applicable local taxes. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in North Dakota must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the North Dakota cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $40M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with North Dakota operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.